>
Switch to:

BridgeBio Pharma Current Deferred Revenue

: $0.00 Mil (As of Dec. 2020)
View and export this data going back to 2019. Start your Free Trial

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

BridgeBio Pharma's current deferred revenue for the quarter that ended in Dec. 2020 was $0.00 Mil.

BridgeBio Pharma Current Deferred Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19 Dec20
Current Deferred Revenue 0.00 0.00 0.00 0.00

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Current Deferred Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BridgeBio Pharma Current Deferred Revenue Related Terms


BridgeBio Pharma Current Deferred Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)